Telix Pharmaceuticals Limited (TLX)

Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care

First Patients Dosed with Telix's FDA-Approved Brain Cancer Imaging Drug Pixclara® (floretyrosine F 18)

IBA and Telix strengthen ties through agreement to distribute ARTMS's QIS®

Wall Street Analysts Believe Telix Pharmaceuticals Limited (TLX) Could Rally 83.42%: Here's is How to Trade

Telix Pharmaceuticals (NASDAQ:TLX) Sees Unusually-High Trading Volume – What’s Next?

Telix Pharmaceuticals Limited (TLX) Discusses Strategic Overview and Oncology Pipeline at Research and Development Day Transcript

Telix Pharmaceuticals Limited (TLX) M&A Call Transcript

Telix and ITM Join Forces to Create a Radiopharmaceutical Powerhouse

Australia's Telix Pharma agrees to buy Germany's ITM Isotope for about $1.65 billion

Telix Pharmaceuticals: 'Buy' On Pixclara FDA Approval And TLX591-Tx Part 2 Advancement

Novo Nordisk vs. Regeneron Pharmaceuticals: Which Healthcare Stock Is a Better Buy in 2026?

Telix Pharmaceuticals Limited (TLX) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

FDA Approves Telix Pharmaceuticals Brain Cancer Imaging Drug

FDA Approves Telix's Brain Cancer Imaging Drug Pixclara

Telix to Present at the Morgan Stanley 24th Annual Global Healthcare Conference and H.C. Wainwright 28th Annual Global Investment Conference

Telix Completes Enrollment in Phase 3 BiPASS Study, Aligns with FDA on NDA Pathway

Telix Appoints David Gill as Chair

Telix Pharmaceuticals: Execution Is The Name Of The Game Here

Telix Pharmaceuticals Limited (TLX) Q2 2026 Earnings Call Transcript

Telix Pharmaceuticals H1 Earnings Call Highlights